摘要
Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) have recently been identified to be closely related to the occurrence and development of atherosclerosis (AS). A growing body of evidence has suggested Chinese medicine takes unique advantages in preventing and treating AS. In this review, the related research progress of AS and LOX-1 has been summarized. And the anti-AS effects of 10 active components of herbal medicine through LOX-1 regulation have been further reviewed. As a potential biomarker and target for intervention in AS, LOX-1 targeted therapy might provide a promising and novel approach to atherosclerotic prevention and treatment.
学科与关键词
关键词
atherosclerosisherbal medicinelectin-like oxidized low-density lipoprotein receptor-1targeted therapy
- LOX-1 in atherosclerosis: biological functions and pharmacological modifiersXu Suowen*; Ogura Sayoko; Chen Jiawei; Little Peter J; Moss Joel; Liu PeiqingCellular and Molecular Life Sciences, 2013, 70(16): 2859-2872.被引 31
- Therapeutic potential of traditional Chinese medicine against atherosclerosis: Targeting trimethylamine N-oxideZhou, Peng; Kang, Jun-li; Cheng, Qi-qing; Chen, Ming-tai; Xie, Ying; Zhou, Hua*PHYTOMEDICINE, 2022, 104: 154305.被引 1
- A review on therapeutical potential of paeonol in atherosclerosisYu, Wei*; Ilyas, Iqra; Aktar, Nasrin; Xu, Suowen*Frontiers in Pharmacology, 2022, 13: 950337.被引 10
